Page last updated: 2024-11-02

oxybutynin and Cancer of Endometrium

oxybutynin has been researched along with Cancer of Endometrium in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
"To assess how women in Sweden with breast cancer (BC), endometrial cancer (EC), and/or pulmonary embolism (PE) were dispensed menopausal hormone therapy (HT)."1.51Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study. ( Fredrikson, M; Hammar, M; Hoffmann, M; Lindh-Åstrand, L; Spetz Holm, AC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindh-Åstrand, L1
Hoffmann, M1
Fredrikson, M1
Hammar, M1
Spetz Holm, AC1

Other Studies

1 other study available for oxybutynin and Cancer of Endometrium

ArticleYear
Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.
    Maturitas, 2019, Volume: 123

    Topics: Aged; Breast Neoplasms; Cohort Studies; Contraindications, Drug; Endometrial Neoplasms; Estrogen Rep

2019